Veterinary Medicines

VANGUARD 7, liofilizat i suspenzija za suspenziju za injekciju, za pse

Authorised
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
  • Canine parvovirus, strain NL-35-D, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain N-CDV, Live
Download as PDF

Product identification

Medicine name:
VANGUARD 7, liofilizat i suspenzija za suspenziju za injekciju, za pse
Active substance:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
  • Canine parvovirus, strain NL-35-D, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain N-CDV, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    463.00
    relative unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
    420.00
    relative unit(s)
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain NL-35-D, Live
    10000000.00
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    1000000.00
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain Manhattan, Live
    1000.00
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain N-CDV, Live
    1000.00
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Available in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/13-01/320
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 23/05/2024
Download